Skip to content

Perspective Therapeutics CATX Investment Purchases

Investment Purchases at other companies

Eli Lilly logo
Eli LillyLLY
$297M+50.8%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$242.78M+1,127%
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
$40.84M+2,021%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$91.32M+28.2%
Precigen logo
PrecigenPGEN
$33.87M+225%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$81.17M+13.6%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's investment purchases?
Perspective Therapeutics (CATX) reported investment purchases of $150.34M in Q1 2026.
How has Perspective Therapeutics's investment purchases changed year-over-year?
Perspective Therapeutics's investment purchases increased by 565.1% year-over-year, from $22.6M to $150.34M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.